The Global Solid Phase Synthesis Carrier for Peptide Drug Market was valued at USD 112 Million in 2024 and is projected to reach USD 221 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period (2024-2032). This substantial growth is being driven by increasing demand for peptide-based therapeutics, advancements in drug discovery technologies, and the superior efficiency of solid-phase synthesis in peptide production.

As the pharmaceutical industry accelerates development of novel peptide drugs across therapeutic areas including oncology, metabolic disorders, and cardiovascular diseases, the focus intensifies on the specialized carriers that enable these critical manufacturing processes. In this analysis, we examine the Top 10 Companies in the Solid Phase Synthesis Carrier Industry—a combination of established material science firms and specialized biotech suppliers shaping the future of peptide therapeutics manufacturing.

🔟 1. Sunresin

Headquarters: Xi’an, China
Key Offering: Hydroxyl resins, Chloromethyl resins, Amino resins

Sunresin is a global leader in separation and purification technologies, supplying high-performance solid phase synthesis carriers to pharmaceutical clients worldwide. Their proprietary resin technologies enable efficient peptide chain elongation with high loading capacities.

Innovation Highlights:

• Patented surface modification technologies for improved coupling efficiency

• Customized carrier solutions for complex peptide sequences

• Expanding GMP manufacturing capabilities in China and Europe

Download FREE Sample Report:
Solid Phase Synthesis Carrier for Peptide Drug Market – View in Detailed Research Report

9️⃣ 2. Tianjin Nankai Hecheng Science & Technology